Peripheral EBV antigen-specific T cell is dysfunctional in Epstein-Barr virus positive diffuse large B-cell lymphoma

Epstein-Barr病毒阳性弥漫性大B细胞淋巴瘤中外周EBV抗原特异性T细胞功能障碍

阅读:2

Abstract

EBV-positive diffuse large B-cell lymphoma (EBV + DLBCL) is associated with poor prognosis, possibly due to the capacity of EBV to dampen host anti-tumor immunity. Patients' peripheral EBV antigen-specific T lymphocytes may be functional deficiency. This study investigated the mechanisms underlying this deficiency by examining the phenotypes and function of peripheral T cells via ELISPOT and flow cytometry. 6 EBV + DLBCL patients, 54 EBV-negative DLBCL (EBV- DLBCL) patients, and 12 healthy controls were enrolled. We observed significantly reduced IFN-γ secreting T cells in EBV + patients upon EBV peptides stimulation compared to EBV-negative patients (P < 0.001), indicating a dysfunction in EBV antigen-specific T cells. Furtherly, compared to EBV- DLBCL, EBV + DLBCL showed decreased proportions of total lymphocytes (P = 0.005), CD8(+) T cells (P = 0.004), CD4(+) T cells central memory (P = 0.017), CD8(+) T cells naïve (P = 0.001), and CD8(+) T cells effector (P = 0.031), alongside increased CD4(+) and CD8(+) effector memory T cells (P = 0.010 and P < 0.001, respectively). Both CD4(+) and CD8(+) T cells demonstrated elevated PD-1 expression (P = 0.045 and P = 0.036, respectively), and the CD4(+)TIM-3(-)CTLA-4(-) population was reduced (P = 0.049), in EBV + DLBCL. There was also a significant decline in CD28(+)KLRG1(-) (P = 0.018) and CD28(+)CD57(-)KLRG1(-) (P = 0.036) subsets among CD8(+) T cells in EBV + patients. CD8(+) T cells showed decreased IFN-γ expression after PMA/BFA stimulation in EBV + DLBCL(P = 0.015). These findings suggested that EBV antigen-specific T cell functional deficits might correlate with altered T cell subset distributions, heightened levels of exhaustion and senescence, and diminished expression of immune effector molecules.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。